Home

Arcus Biosciences, Inc. (RCUS)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Arcus Biosciences, Inc. (RCUS)

Go deeper and ask any question about RCUS

Company Performance

Current Price

as of Sep 17, 2024

$16.73

P/E Ratio

N/A

Market Cap

$1.53B

Description

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Metrics

Overview

  • HQHayward, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerRCUS
  • Price$16.73-1.01%

Trading Information

  • Market Cap$1.53B
  • Float53.29%
  • Average Daily Volume (1m)573,531
  • Average Daily Volume (3m)645,969
  • EPS-$3.10

Company

  • Revenue$247.00M
  • Rev Growth (1yr)34.48%
  • Net Income-$93.00M
  • Gross Margin94.87%
  • EBITDA Margin-266.67%
  • EBITDA-$104.00M
  • EV$429.45M
  • EV/Revenue1.74
  • P/EN/A
  • P/S6.17
Documents